BiotechTube
Home/Wockhardt/Dr. Habil F. Khorakiwala
DH

Dr. Habil F. Khorakiwala

Founder and Chairman

Wockhardt

Therapeutic Areas

Infectious DiseaseDiabetesHospital & Critical Care

Wockhardt Pipeline

DrugIndicationPhase
Zaynich (WCK 5222)cUTI, HABP/VABP caused by MDR Gram-negative bacteriaNDA Filed
WCK 5153Resistant Gram-negative infectionsPhase I
ZoliflodacinUncomplicated GonorrheaPhase III
WCK 4282Resistant Hospital-Acquired InfectionsPreclinical/Phase I
Biosimilar Insulin GlargineDiabetes MellitusLaunched
Biosimilar Insulin AspartDiabetes MellitusLaunched

Leadership Team at Wockhardt

DM
Dr. Murtaza Khorakiwala
Managing Director
MR
Mr. Rajesh Arora
Chief Financial Officer
DZ
Dr. Zoher Sihorwala
Senior Vice President and Head – Drug Regulatory Affairs
DV
Dr. Vinod Ahirrao
Senior Group Leader - Analytical Chemistry, Drug Discovery Research
View full Wockhardt profile